Neurology
Stroke and thrombectomy, epilepsy, Parkinson's, multiple sclerosis, dementias and anti-amyloid antibodies, headache and neuromuscular disease.
Published issues
- What's next in neurology — November 13, 2026
This issue covers four milestones between December 4, 2026 and May 1, 2027: the AES annual epilepsy meeting and three FDA reviews in rare diseases (pyruvate dehydrogenase complex deficiency, spinocerebellar ataxia, and…
🎧 ListenAudio newscast · 4:22 min - Monthly neurology bulletin — November 3, 2026
Period covered: October 9 to November 3, 2026 (since the previous issue of October 8). The month was shaped by MSToronto2026, the joint ACTRIMS-ECTRIMS meeting (Toronto, October 21–23), with phase 3 data for two BTK…
🎧 ListenAudio newscast · 6:04 min - What's next in neurology — October 13, 2026
This edition covers what is coming in neurology between mid-November 2026 and the first half of 2027: a phase 3 readout in early Alzheimer disease, three FDA decisions with published dates (Duchenne muscular dystrophy,…
🎧 ListenAudio newscast · 5:02 min - Monthly neurology bulletin — October 8, 2026
Period covered: September 8 to October 8, 2026. The month was dominated by the MDS Congress in Seoul (movement disorders), FDA regulatory actions in Parkinson disease, multiple sclerosis and epilepsy, and a Chinese…
🎧 ListenAudio newscast · 5:01 min - Monthly neurology bulletin — September 28, 2026
Colleagues: this issue covers August 29 to September 28, 2026. It was a month driven by regulatory decisions (FDA, EMA, PMDA and ANVISA), with few new trials in acute stroke. We selected 13 verified items; five come…
🎧 ListenAudio newscast · 6:23 min